Inflammatory Breast Cancer (IBC) Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00477100|
Recruitment Status : Recruiting
First Posted : May 22, 2007
Last Update Posted : March 7, 2018
The goal of this research study is to collect blood and tissue samples and clinical data from patients with inflammatory breast cancer (IBC) or highly suspicious for IBC. The blood and tissue samples and clinical data will be stored in a research tissue bank and used to help researchers try to better understand IBC.
This is an investigational study. Up to 1200 patients will take part in this study. Up to 1000 will be enrolled at MD Anderson.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Other: Interview Procedure: Blood and Tissue Collection|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||1200 participants|
|Official Title:||Inflammatory Breast Cancer (IBC) Registry|
|Actual Study Start Date :||April 2007|
|Estimated Primary Completion Date :||April 2020|
|Estimated Study Completion Date :||April 2021|
Blood & Tissue Collection + Interview
Personal InterviewProcedure: Blood and Tissue Collection
Blood (about 4 tablespoons) collected during routine blood draw, breast tissue collected at the time of standard diagnostic procedure, and a core and a skin biopsy collected at the time of standard diagnostic procedure.
- Number of patients with untreated newly diagnosed IBC participating in Registry [ Time Frame: 6 Years ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00477100
|Contact: Jie Willey, MSN, BSN||713-792-3965|
Show 19 Study Locations
|Principal Investigator:||Naoto Ueno, MD, PHD||M.D. Anderson Cancer Center|